Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Olivia Scheyer"'
Autor:
Nabeel Saif, Cara Berkowitz, Susmit Tripathi, Olivia Scheyer, Emily Caesar, Hollie Hristov, Katherine Hackett, Aneela Rahman, Newman Knowlton, George Sadek, Paige Lee, Mark McInnis, Richard S. Isaacson
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Low awareness of Alzheimer's disease (AD) clinical trials is a recruitment barrier. To assess whether online education may affect screening rates for AD prevention clinical trials, we conducted an initial prospective cohort stud
Externí odkaz:
https://doaj.org/article/5606a4dad42341cbb72020239c7e0d0f
Autor:
Matthew W. Schelke, Peter Attia, Daniel J. Palenchar, Bob Kaplan, Monica Mureb, Christine A. Ganzer, Olivia Scheyer, Aneela Rahman, Robert Kachko, Robert Krikorian, Lisa Mosconi, Richard S. Isaacson
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
Alzheimer’s disease (AD) is a neurodegenerative dementia that affects nearly 50 million people worldwide and is a major source of morbidity, mortality, and healthcare expenditure. While there have been many attempts to develop disease-modifying the
Externí odkaz:
https://doaj.org/article/9a087b895cd5414497292343947ee060
Autor:
Lisa Mosconi, Aneela Rahman, Ivan Diaz, Xian Wu, Olivia Scheyer, Hollie Webb Hristov, Shankar Vallabhajosula, Richard S Isaacson, Mony J de Leon, Roberta Diaz Brinton
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0207885 (2018)
Two thirds of all persons with late-onset Alzheimer's disease (AD) are women. Identification of sex-based molecular mechanisms underpinning the female-based prevalence of AD would advance development of therapeutic targets during the prodromal AD pha
Externí odkaz:
https://doaj.org/article/1c4150fb5afa40e7aa5299eb3e8a6279
Autor:
Lisa Mosconi, Samuel P. Dickson, Hollie Hristov, Matthew E. Fink, Aneela Rahman, George Sadek, Juan C. Meléndez, Kellyann Niotis, Suzanne Hendrix, Robert Krikorian, Christine Greer, Mu Ji Hwang, Pei-lin Lu, Joseph Safdieh, Richard S. Isaacson, Josefina Meléndez-Cabrero, Olivia Scheyer, Matthew W. Schelke, Sonia Bellara, Katherine Hackett, Paige Lee, Madhav Thambisetty, Emily Caesar, Peter Attia, Cara Berkowitz, Monica Mureb, Nabeel Saif, Randy Cohen
Publikováno v:
Alzheimer's & Dementia. 15:1588-1602
INTRODUCTION: Multi-domain intervention for Alzheimer’s disease (AD) risk reduction is an emerging therapeutic paradigm. METHODS: Patients were prescribed individually-tailored interventions (education/pharmacologic/non-pharmacologic) and rated on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd27fc1f3d485253129ffd84b3743e16
https://doi.org/10.1016/j.jalz.2019.08.198
https://doi.org/10.1016/j.jalz.2019.08.198
Autor:
Olivia Scheyer, Ariane Lewis
Publikováno v:
Chest. 155:1234-1245
Background There have been a number of prominent lawsuits challenging the use of neurologic criteria to declare death in the United States. Methods To put these lawsuits into perspective, we conducted a search of Nexis Uni to identify cases from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd57ec2becbf5db37f4a65be14065da
https://doi.org/10.1016/j.chest.2019.03.018
https://doi.org/10.1016/j.chest.2019.03.018
Autor:
George Sadek, Kellyann Niotis, Aneela Rahman, Robert Krikorian, Olivia Scheyer, P. Yan, Richard S. Isaacson, Nabeel Saif, Sonia Bellara, Hollie Hristov, M. Berkowitz
Publikováno v:
J Prev Alzheimers Dis
Background: Alzheimer’s disease (AD) is the most common and most costly chronic neurodegenerative disease globally. AD develops over an extended period prior to cognitive symptoms, leaving a “window of opportunity” for targeted risk-reduction i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26e9fdb1419eba38cf0a1cede03cf88
https://doi.org/10.14283/jpad.2019.39
https://doi.org/10.14283/jpad.2019.39
Autor:
Richard S. Isaacson, George Sadek, Kellyann Niotis, Yasmin Amini, Moises Dominguez, Hollie Hristov, Newman Knowlton, Mark McInnis, Paige Lee, Olivia Scheyer, John F. Hodes, Michael Woodbury, Emily Caesar, Nabeel Saif
Publikováno v:
Neurology
ObjectiveAlzheimer disease (AD) risk factors are present throughout the lifespan. This randomized controlled trial evaluated the effectiveness of various online education strategies concerning AD risk reduction and brain health in younger populations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e4d31ce926bbf532c3815e02ae5f14
https://pubmed.ncbi.nlm.nih.gov/32665410
https://pubmed.ncbi.nlm.nih.gov/32665410
Autor:
Cara L. Berkowitz, Lisa Mosconi, Olivia Scheyer, Aneela Rahman, Hollie Hristov, Richard S. Isaacson
Publikováno v:
The Road from Nanomedicine to Precision Medicine ISBN: 9780429295010
The Road from Nanomedicine to Precision Medicine ISBN: 9781003027010
The Road from Nanomedicine to Precision Medicine ISBN: 9781003027010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dd9081f0342e4452a873ec15a09f0c
https://doi.org/10.1201/9780429295010-11
https://doi.org/10.1201/9780429295010-11
Autor:
Olivia Scheyer, Mark McInnis, Alon Seifan, Jon Isaacson, Katherine Hackett, Lisa Mosconi, Joseph Safdieh, Richard S. Isaacson, Monica Mureb, Jaclyn L. Chen, Emily Caesar, Aneela Rahman, Candace L. Haddox
Publikováno v:
Journal of Communication in Healthcare. 11:106-113
The use of social media may be a valuable tool for dissemination of patient education interventions. However, in Alzheimer's disease (AD), little data exists about the effectiveness, associated cost, or conditions for utilization.Alzheimer's Universe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e5456ebb6ef9a6ae75bc7e22eb4450
https://doi.org/10.1080/17538068.2018.1467068
https://doi.org/10.1080/17538068.2018.1467068
Autor:
Olivia Scheyer, Hollie Hristov, Aneela Rahman, Lisa Mosconi, Cara Berkowitz, Richard S. Isaacson
Publikováno v:
The Journal Of Prevention of Alzheimer's Disease. :1-7
Population-attributable risk models estimate that up to one-third of Alzheimer’s disease (AD) cases may be preventable through risk factor modification. The field of AD prevention has largely focused on addressing these factors through universal ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6090f63e2d03888cf67e47a2b776ce28
https://doi.org/10.14283/jpad.2018.35
https://doi.org/10.14283/jpad.2018.35